Glenmark's anti-diabetic drug biosimilar claims to cut therapy cost by 70%
The drug is being marketed under the brand name ‘Lirafit’, following approval from the Drug Controller General of India.
glenmark
January 2024
September 2023
Glenmark sells bulk drug business to Nirma for ₹5,651 cr
GLS is a leading developer and manufacturer of active pharmaceutical ingredients, while FMCG major Nirma makes products from cosmetics to soaps to detergents
